Targeting the provirus in HIV-1 latently infected cells with a cell-activation-inducible CRISPR-Cas9 system: An in vitro proof of concept. // Molecular Therapy: Nucleic Acids. – URL: https://www.sciencedirect.com/science/article/pii/S216225312600329X?dgcid=rss_sd_all
Targeting the provirus in HIV-1 latently infected cells with a cell-activation-inducible CRISPR-Cas9 system: An in vitro proof of concept. Molecular Therapy: Nucleic Acids. https://www.sciencedirect.com/science/article/pii/S216225312600329X?dgcid=rss_sd_all
“Targeting the provirus in HIV-1 latently infected cells with a cell-activation-inducible CRISPR-Cas9 system: An in vitro proof of concept.” Molecular Therapy: Nucleic Acids.
@article{article59041,
title = {Targeting the provirus in HIV-1 latently infected cells with a cell-activation-inducible CRISPR-Cas9 system: An in vitro proof of concept},
journal = {Molecular Therapy: Nucleic Acids},
url = {https://www.sciencedirect.com/science/article/pii/S216225312600329X?dgcid=rss_sd_all}
}